Form Type: 4/A

SEC EDGAR Link
Accession Number:0001104659-20-082855
Date:2020-01-07
Issuer: AKERO THERAPEUTICS, INC. (AKRO)
Original Submission Date:2020-01-09

Reporting Person:

VERSANT VENTURE CAPITAL VI, L.P.
ONE SANSOME STREET,
SUITE 3630 SAN FRANCISCO, CA 94104

Reporting Person:

VERSANT VENTURES VI GP, L.P.
ONE SANSOME STREET,
SUITE 3630 SAN FRANCISCO, CA 94104

Reporting Person:

VERSANT VENTURES VI GP-GP, LLC
ONE SANSOME STREET,
SUITE 3630 SAN FRANCISCO, CA 94104

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-01-07 S 14,162 d $20.05 2,885,836 indirect f3
COMMON STOCK 2020-01-08 S 22,368 d $19.80 2,863,468 indirect f3
COMMON STOCK 2020-01-09 S 16,527 d $20.21 2,846,941 indirect f3
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the sales reported in this form 4 were effected pursuant to a 10b5-1 trading plan.
f2 these sales were executed in multiple trades at prices ranging from $19.77 to $20.73. the price reported above reflects the weighted average sale price. the reporting persons hereby undertake to provide full information regarding the number of shares and prices at which these sales were effected, upon request, to the staff of the securities and exchange commission, the issuer or a security holder of the issuer.
f3 these shares are owned directly by versant venture capital vi, l.p. ("versant vi"). versant ventures vi gp, l.p. ("versant gp lp") is the general partner of versant vi and versant ventures vi gp-gp, llc ("versant gp llc") is the general partner of versant gp lp and the ultimate general partner of versant vi. versant gp lp and versant gp llc may be deemed to have voting and investment power over the securities held by versant vi and as a result may be deemed to have beneficial ownership over such securities. versant gp lp and versant gp llc disclaim beneficial ownership over these securities except to the extent of their respective pecuniary interests therein.
f4 these sales were executed in multiple trades at prices ranging from $19.81 to $20.19. the price reported above reflects the weighted average sale price. the reporting persons hereby undertake to provide full information regarding the number of shares and prices at which these sales were effected, upon request, to the staff of the securities and exchange commission, the issuer or a security holder of the issuer.
f5 these sales were executed in multiple trades at prices ranging from $19.82 to $20.41. the price reported above reflects the weighted average sale price. the reporting persons hereby undertake to provide full information regarding the number of shares and prices at which these sales were effected, upon request, to the staff of the securities and exchange commission, the issuer or a security holder of the issuer.
WhaleWisdom Logo

Elevate your investments